Technical Analysis for GBIM - Globeimmune Cm

Grade Last Price % Change Price Change
grade F 0.079 17.04% 0.0115
GBIM closed up 17.04 percent on Wednesday, October 16, 2019, on 80 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical GBIM trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish 17.04%
Fell Below 50 DMA Bearish 17.04%
MACD Bearish Signal Line Cross Bearish 17.04%
180 Bearish Setup Bearish Swing Setup 17.04%
Narrow Range Bar Range Contraction 17.04%
Inside Day Range Contraction 17.04%
Wide Bands Range Expansion 17.04%
20 DMA Support Bullish -16.40%

Older signals for GBIM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GlobeImmune, Inc. is a biopharmaceutical company. The Company is focused on developing products for the treatment of cancer and infectious diseases based on its Tarmogen platform. The Company's segment is the business of developing and commercializing various biopharmaceutical products. The Company's infectious disease product candidates include GS-4774, which is in Phase II for the treatment of chronic hepatitis B infection; GI-19000; GI-2010, which is in the preclinical stage of development for the treatment of Human immunodeficiency virus (HIV), and GI-18000, which is in the preclinical stage of development for the treatment of Chronic hepatitis D infection. The Company's oncology product candidates include GI-6207, which is in Phase II for the treatment of medullary thyroid cancer; GI-6301, and GI-4000, which is in Phase IIb for the treatment of Resected pancreas cancer, and in Phase II for the treatment of Non-small cell lung cancer and colorectal cancer.
Medicine RTT Medical Specialties Cancer Biopharmaceutical Infectious Diseases Treatment Of Cancer Hiv Colorectal Cancer Hepatitis Biopharmaceutical Products Infectious Disease Non Small Cell Lung Cancer Infectious Causes Of Cancer Treatment Of Non Small Cell Lung Cancer
Is GBIM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.6
52 Week Low 0.0351
Average Volume 18,761
200-Day Moving Average 0.1967
50-Day Moving Average 0.0928
20-Day Moving Average 0.0898
10-Day Moving Average 0.085
Average True Range 0.0242
ADX 9.34
+DI 23.8348
-DI 32.3009
Chandelier Exit (Long, 3 ATRs ) 0.0624
Chandelier Exit (Short, 3 ATRs ) 0.1376
Upper Bollinger Band 0.1221
Lower Bollinger Band 0.0575
Percent B (%b) 0.33
BandWidth 71.937639
MACD Line -0.0037
MACD Signal Line -0.0029
MACD Histogram -0.0008
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0963
Resistance 3 (R3) 0.0943 0.0867 0.0934
Resistance 2 (R2) 0.0867 0.0823 0.0876 0.0924
Resistance 1 (R1) 0.0828 0.0796 0.0848 0.0848 0.0915
Pivot Point 0.0752 0.0752 0.0761 0.0761 0.0752
Support 1 (S1) 0.0713 0.0708 0.0733 0.0733 0.0665
Support 2 (S2) 0.0637 0.0681 0.0646 0.0656
Support 3 (S3) 0.0598 0.0637 0.0646
Support 4 (S4) 0.0618